Adverts

Open Access Articles- Top Results for PD-217,014

PD-217,014

</th></tr>
PD-217,014
175px
Systematic (IUPAC) name
(1α,3α,5α)-3-aminomethyl-bicyclo[3.2.0]heptane-3-acetic acid
Clinical data
Identifiers
444088-20-4 7pxY
PubChem CID 10313401
Chemical data
Formula C10H17NO2
183.247 g/mol

PD-217,014 is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2). It was developed as a potentially more potent successor to gabapentin and pregabalin, along with several other analogues such as atagabalin and 4-methylpregabalin, but while PD-217,014 produces visceral analgesic effects in animal studies with higher potency and efficacy than gabapentin, it was not developed further for clinical use because of its comparatively more complex synthesis, compared to other related analogues.[1]

References

  1. ^ Ohashi K, Kawai M, Ninomiya N, Taylor C, Kurebayashi Y. Effect of a new alpha 2 delta ligand PD-217014 on visceral hypersensitivity induced by 2,4,6-trinitrobenzene sulfonic acid in rats. Pharmacology. 2008;81(2):144-50. PMID 17989503



Lua error in package.lua at line 80: module 'Module:Buffer' not found.